Selenium and type 2 diabetes

Systematic review

Lindsay N. Kohler, Janet A Foote, Connor P. Kelley, Ana Florea, Colleen Shelly, Hsiao-Hui Chow, Chiu-Hsieh Hsu, Ken Batai, Nathan Ellis, Kathylynn Saboda, Michael P Lance, Elizabeth T Jacobs

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Several studies have investigated the potential role of selenium (Se) in the development of type 2 diabetes (T2D) with disparate findings. We conducted a systematic review and meta-analysis to synthesize the evidence of any association between Se and T2D. PubMed, Embase, and Scopus were searched following the Preferred Reporting Items for Systematic Reviews and Meta-analysis Approach (PRISMA). Sixteen studies from 15 papers met inclusion criteria defined for this review. Of the 13 observational studies included, 8 demonstrated a statistically significant positive association between concentrations of Se and odds for T2D, with odds ratios (95% confidence intervals) ranging from 1.52 (1.01–2.28) to 7.64 (3.34–17.46), and a summary odds ratio (OR) (95% confidence interval (CI)) of 2.03 (1.51–2.72). In contrast, among randomized clinical trials (RCTs) of Se, a higher risk of T2D was not observed for those who received Se compared to a placebo (OR = 1.18, 95% CI 0.95–1.47). Taken together, the results for the relationship between Se and T2D differ between observational studies and randomized clinical trials (RCTs). It remains unclear whether these differences are the result of uncontrolled confounding in the observational studies, or whether there is a modest effect of Se on the risk for T2D that may vary by duration of exposure. Further investigations on the effects of Se on glucose metabolism are needed.

Original languageEnglish (US)
Article number1924
JournalNutrients
Volume10
Issue number12
DOIs
StatePublished - Dec 1 2018

Fingerprint

systematic review
Selenium
noninsulin-dependent diabetes mellitus
Type 2 Diabetes Mellitus
selenium
observational studies
odds ratio
Observational Studies
confidence interval
randomized clinical trials
Odds Ratio
Confidence Intervals
meta-analysis
Meta-Analysis
Randomized Controlled Trials
PubMed
placebos
exposure duration
Placebos
Glucose

Keywords

  • Glucose
  • Insulin resistance
  • Review
  • Selenium
  • Selenium supplementation
  • Type 2 diabetes

ASJC Scopus subject areas

  • Food Science
  • Nutrition and Dietetics

Cite this

Selenium and type 2 diabetes : Systematic review. / Kohler, Lindsay N.; Foote, Janet A; Kelley, Connor P.; Florea, Ana; Shelly, Colleen; Chow, Hsiao-Hui; Hsu, Chiu-Hsieh; Batai, Ken; Ellis, Nathan; Saboda, Kathylynn; Lance, Michael P; Jacobs, Elizabeth T.

In: Nutrients, Vol. 10, No. 12, 1924, 01.12.2018.

Research output: Contribution to journalReview article

Kohler LN, Foote JA, Kelley CP, Florea A, Shelly C, Chow H-H et al. Selenium and type 2 diabetes: Systematic review. Nutrients. 2018 Dec 1;10(12). 1924. https://doi.org/10.3390/nu10121924
Kohler, Lindsay N. ; Foote, Janet A ; Kelley, Connor P. ; Florea, Ana ; Shelly, Colleen ; Chow, Hsiao-Hui ; Hsu, Chiu-Hsieh ; Batai, Ken ; Ellis, Nathan ; Saboda, Kathylynn ; Lance, Michael P ; Jacobs, Elizabeth T. / Selenium and type 2 diabetes : Systematic review. In: Nutrients. 2018 ; Vol. 10, No. 12.
@article{ee63e93c5aff4f4eb940a966491dca9c,
title = "Selenium and type 2 diabetes: Systematic review",
abstract = "Several studies have investigated the potential role of selenium (Se) in the development of type 2 diabetes (T2D) with disparate findings. We conducted a systematic review and meta-analysis to synthesize the evidence of any association between Se and T2D. PubMed, Embase, and Scopus were searched following the Preferred Reporting Items for Systematic Reviews and Meta-analysis Approach (PRISMA). Sixteen studies from 15 papers met inclusion criteria defined for this review. Of the 13 observational studies included, 8 demonstrated a statistically significant positive association between concentrations of Se and odds for T2D, with odds ratios (95{\%} confidence intervals) ranging from 1.52 (1.01–2.28) to 7.64 (3.34–17.46), and a summary odds ratio (OR) (95{\%} confidence interval (CI)) of 2.03 (1.51–2.72). In contrast, among randomized clinical trials (RCTs) of Se, a higher risk of T2D was not observed for those who received Se compared to a placebo (OR = 1.18, 95{\%} CI 0.95–1.47). Taken together, the results for the relationship between Se and T2D differ between observational studies and randomized clinical trials (RCTs). It remains unclear whether these differences are the result of uncontrolled confounding in the observational studies, or whether there is a modest effect of Se on the risk for T2D that may vary by duration of exposure. Further investigations on the effects of Se on glucose metabolism are needed.",
keywords = "Glucose, Insulin resistance, Review, Selenium, Selenium supplementation, Type 2 diabetes",
author = "Kohler, {Lindsay N.} and Foote, {Janet A} and Kelley, {Connor P.} and Ana Florea and Colleen Shelly and Hsiao-Hui Chow and Chiu-Hsieh Hsu and Ken Batai and Nathan Ellis and Kathylynn Saboda and Lance, {Michael P} and Jacobs, {Elizabeth T}",
year = "2018",
month = "12",
day = "1",
doi = "10.3390/nu10121924",
language = "English (US)",
volume = "10",
journal = "Nutrients",
issn = "2072-6643",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",

}

TY - JOUR

T1 - Selenium and type 2 diabetes

T2 - Systematic review

AU - Kohler, Lindsay N.

AU - Foote, Janet A

AU - Kelley, Connor P.

AU - Florea, Ana

AU - Shelly, Colleen

AU - Chow, Hsiao-Hui

AU - Hsu, Chiu-Hsieh

AU - Batai, Ken

AU - Ellis, Nathan

AU - Saboda, Kathylynn

AU - Lance, Michael P

AU - Jacobs, Elizabeth T

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Several studies have investigated the potential role of selenium (Se) in the development of type 2 diabetes (T2D) with disparate findings. We conducted a systematic review and meta-analysis to synthesize the evidence of any association between Se and T2D. PubMed, Embase, and Scopus were searched following the Preferred Reporting Items for Systematic Reviews and Meta-analysis Approach (PRISMA). Sixteen studies from 15 papers met inclusion criteria defined for this review. Of the 13 observational studies included, 8 demonstrated a statistically significant positive association between concentrations of Se and odds for T2D, with odds ratios (95% confidence intervals) ranging from 1.52 (1.01–2.28) to 7.64 (3.34–17.46), and a summary odds ratio (OR) (95% confidence interval (CI)) of 2.03 (1.51–2.72). In contrast, among randomized clinical trials (RCTs) of Se, a higher risk of T2D was not observed for those who received Se compared to a placebo (OR = 1.18, 95% CI 0.95–1.47). Taken together, the results for the relationship between Se and T2D differ between observational studies and randomized clinical trials (RCTs). It remains unclear whether these differences are the result of uncontrolled confounding in the observational studies, or whether there is a modest effect of Se on the risk for T2D that may vary by duration of exposure. Further investigations on the effects of Se on glucose metabolism are needed.

AB - Several studies have investigated the potential role of selenium (Se) in the development of type 2 diabetes (T2D) with disparate findings. We conducted a systematic review and meta-analysis to synthesize the evidence of any association between Se and T2D. PubMed, Embase, and Scopus were searched following the Preferred Reporting Items for Systematic Reviews and Meta-analysis Approach (PRISMA). Sixteen studies from 15 papers met inclusion criteria defined for this review. Of the 13 observational studies included, 8 demonstrated a statistically significant positive association between concentrations of Se and odds for T2D, with odds ratios (95% confidence intervals) ranging from 1.52 (1.01–2.28) to 7.64 (3.34–17.46), and a summary odds ratio (OR) (95% confidence interval (CI)) of 2.03 (1.51–2.72). In contrast, among randomized clinical trials (RCTs) of Se, a higher risk of T2D was not observed for those who received Se compared to a placebo (OR = 1.18, 95% CI 0.95–1.47). Taken together, the results for the relationship between Se and T2D differ between observational studies and randomized clinical trials (RCTs). It remains unclear whether these differences are the result of uncontrolled confounding in the observational studies, or whether there is a modest effect of Se on the risk for T2D that may vary by duration of exposure. Further investigations on the effects of Se on glucose metabolism are needed.

KW - Glucose

KW - Insulin resistance

KW - Review

KW - Selenium

KW - Selenium supplementation

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85058047369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058047369&partnerID=8YFLogxK

U2 - 10.3390/nu10121924

DO - 10.3390/nu10121924

M3 - Review article

VL - 10

JO - Nutrients

JF - Nutrients

SN - 2072-6643

IS - 12

M1 - 1924

ER -